SCHEMBL6312145

SCHEMBL6312145

Cc1c(Cc2ccc(F)cc2)c(N2CC[C@H](N(C)C)C2)n2c(nc3ccccc32)c1C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.50
HIF1A Q16665 1/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
KDM4E B2RXH2 6/20 0.49
HSP90AA1 P07900 2/20 0.49
MAPK1 P28482 1/20 0.49
MCL1 Q07820 1/20 0.49
CYP2D6 P10635 2/20 0.48
HRH1 P35367 2/20 0.48
KCNH2 Q12809 1/20 0.48
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 1/20 0.47
TSHR P16473 2/20 0.47
ALDH1A1 P00352 7/20 0.47
HPGD P15428 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GLA P06280 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6312411 0.92 MEN1 (0.51) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6310652 0.92 NPSR1 (0.50) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6311985 0.91 NPSR1 (0.48) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6311896 0.90 HRH1 (0.54) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6318897 0.89 ALDH1A1 (0.50) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6319701 0.89 NPSR1 (0.47) NPSR1HIF1AMEN1KMT2AKDM4E
Formic Acid SCHEMBL6312631 0.89 KDM4E (0.51) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6310986 0.88 NPSR1 (0.47) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6311088 0.88 KDM4E (0.49) NPSR1HIF1AMEN1KMT2AKDM4E
SCHEMBL6310523 0.87 ALDH1A1 (0.51) NPSR1HIF1AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 NPSR1 1531/4885HIF1A 2992/4885MEN1 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.